ResearcherTaichung Veterans General HospitalActive in the last 2 years

Hsin‐Chen Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2780-520X; OpenAlex author ID A5085227867. Sources: OpenAlex.

Their work

Papers: 4 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 12

Papers, trials and grants by year

2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 4

Gemcitabine/nab-paclitaxel plus S-1 combination compared with gemcitabine/nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: a retrospective study. Last author DOI 10.1177/17588359261420081 ↗
The clinical outcomes of adjuvant gemcitabine plus S-1 in resected pancreatic cancer: a single-center retrospective study. Last author DOI 10.1186/s12885-025-14617-8 ↗
Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. Co-author DOI 10.1016/j.bj.2023.100696 ↗
The concomitant use of the renin-angiotensin system inhibitors and survival outcomes of patients with pancreatic adenocarcinoma: an analysis from a tertiary ce… Co-author DOI 10.1177/17588359241247019 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kuan-Yu Tseng · 3 shared papers, 2024–2026 · strength 0.96
Cheng‐Wei Chou · 1 shared paper, 2024 · strength 0.24
- Paper The concomitant use of the renin-angiotensin system inhibitors and survival outcomes of patients with pancreatic adenoc… DOI 10.1177/17588359241247019 ↗
Yen‐Yang Chen · 1 shared paper, 2024 · strength 0.19
- Paper Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. DOI 10.1016/j.bj.2023.100696 ↗
Nai‐Jung Chiang · 1 shared paper, 2024 · strength 0.19
- Paper Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. DOI 10.1016/j.bj.2023.100696 ↗
Jen‐Shi Chen · 1 shared paper, 2024 · strength 0.19
- Paper Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. DOI 10.1016/j.bj.2023.100696 ↗
Wen‐Chi Chou · 1 shared paper, 2024 · strength 0.19
- Paper Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. DOI 10.1016/j.bj.2023.100696 ↗
Yung‐Yeh Su · 1 shared paper, 2024 · strength 0.19
- Paper Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. DOI 10.1016/j.bj.2023.100696 ↗
Chien‐Jui Huang · 1 shared paper, 2024 · strength 0.19
- Paper Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. DOI 10.1016/j.bj.2023.100696 ↗
Tai‐Jan Chiu · 1 shared paper, 2024 · strength 0.19
- Paper Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. DOI 10.1016/j.bj.2023.100696 ↗
Li‐Yuan Bai · 1 shared paper, 2024 · strength 0.19
- Paper Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. DOI 10.1016/j.bj.2023.100696 ↗
Chung‐Pin Li · 1 shared paper, 2024 · strength 0.19
- Paper Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. DOI 10.1016/j.bj.2023.100696 ↗
Shih‐Hung Yang · 1 shared paper, 2024 · strength 0.19
- Paper Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. DOI 10.1016/j.bj.2023.100696 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.